. 2018 Oct 10;13(10):e0204334. doi: 10.1371/journal.pone.0204334

Table 4. Univariate and multivariate analysis of the effects of CTC/SCC and disease-free survival in patients with cervical cancer.

Clinicopathological characteristics	Univariate analysis		Multivariate analysis
Clinicopathological characteristics	HR (95% CI)	P value	HR (95% CI)	P value
FIGO stage (IV vs. III vs. II)	2.202 (1.458–3.326)	0.000	1.671 (1.110–2.516)	0.014
CTC/SCC combination status (Low vs. Intermediate vs. High)	2.711 (1.790–4.106)	0.000	2.386 (1.548–3.678)	0.000

NOTE: CTC, circulating tumor cells; SCC-Ag, Squamous cell carcinoma antigen; FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio; CI, confidence interval. The bold type represents P values smaller than 0.05.